Jennings Strouss Sponsors the 5th Annual Commercializing Life Sciences Forum: The Art and Science of Valuing a Bioscience Company

Jennings Strouss, is again partnering with ASU Technopolis and other entities to co-sponsor the 5th Annual Commercializing Life Sciences Forum (“Conference”) on September 1, 2009 in Scottsdale, Arizona at ASU’s Skysong campus. This year’s Conference, entitled The Art and Science of Valuing a Bioscience Company, will focus on the challenges of valuing inventions and other key IP held by a bioscience entity from discovery to the mature commercialization stage.

• Session 1: Valuation of Intellectual PropertyPanel Discussion: Determine an appropriate valuation for a technology and its associated IP.
• Session 2: Company Valuation when Attracting InvestmentPanel Discussion: Issues surrounding the funding of an existing company, e.g., maintaining the founder's stake, down rounds, how to avoid setting a valuation that will make it harder to attract additional capital later.
• Session 3: Valuation in an M&A EnvironmentPanel Discussion: How a company is valued when it is being considered for an acquisition.

Other Conference supporters include the Arizona BioIndustry Association, the Mayo Clinic, SunHealth Research Institute, and Arizona Technology Enterprises (AzTE).

For additional information, please visit Jennings Strouss or ASU Technopolis or contact Frank X. Curci.

Save the Date postcard.